3 of the Best Growth Stocks You Can Buy for Less than $100 [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
But investors should know that there are plenty of good growth stock options worth considering for the long haul that won't cost you a fortune. Aside from the cheaper price, exploring cheaper alternatives can also help to spread your investment dollars around, ensuring diversity as you buy in on good companies when they are still in their early growth stages. Just remember that doing so means buying in when there may still be some price volatility and risk involved. Are You Missing The Morning Scoop? Breakfast News delivers it all in a quick, Foolish, and free daily newsletter. Sign Up For Free » If you're looking at investments priced at less than $100, then three of the best growth stocks to consider right now are CRISPR Therapeutics (NASDAQ: CRSP) Celsius (NASDAQ: CELH) , and KB Home (NYSE: KBH) . Here's what you need to know about these three lower-priced stocks. An up-and-coming healthcare stock investors may want to consider loading up on for the long term is CRISPR Ther
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $94.00 price target on the stock.MarketBeat
- CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual MeetingGlobeNewswire
- 2 Biotech Stocks to Buy Hand Over Fist in December [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 11/5/24 - Beat
CRSP
Sec Filings
- 12/10/24 - Form SC
- 12/4/24 - Form 4
- 11/13/24 - Form 4
- CRSP's page on the SEC website